Sera Prognostics
SERA • NASDAQ
Sera Prognostics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Zhenya Lindgardt, with a market cap of $81.8M.
Market Cap$81.8M
Employees57.0
CEOZhenya Lindgardt
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Sera Prognostics FAQ
Common questions about Sera Prognostics
Sera Prognostics is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $118.0K.
Sera Prognostics has approximately 57 employees.